GlassScriptPhysician profile
Armand C Wood
NPI 1548297526
$7,260.47
in general payments reported to CMS, 2019-2025
51 companies · $996 in 2025
The $996 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,365 · 2020: $326 · 2021: $1,124 · 2022: $1,663 · 2023: $1,389 · 2024: $398 · 2025: $996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,764 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,764.16 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,405.72 | 2019-2025 | |
| Abbvie INC. | $869.64 | 2019-2025 | Ubrelvy, Vraylar, Qulipta |
| Glaxosmithkline, LLC. | $689.10 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $521.80 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $357.27 | 2022-2024 | Freestyle Libre 3, Eterna |
| Amgen INC. | $260.38 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $258.92 | 2019-2024 | Eliquis, Camzyos |
| Lilly USA, LLC | $257.02 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Janssen Pharmaceuticals, INC | $249.09 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $207.99 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.11 | 2019-2025 | Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $171.49 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $163.68 | 2019-2025 | Airsupra, Breztri |
| Daiichi Sankyo INC. | $138.87 | 2019-2024 | Injectafer |
| Amarin Pharma, INC. | $138.63 | 2020-2022 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armand Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.